ANI Pharma Inc (ANIP)

May 27, 2025, 4:30 PM EDT - 8 days ago

ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference

May 27, 2025, 7:20 AM EDT - 8 days ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter

AGL OMER

May 22, 2025, 6:50 AM EDT - 13 days ago

ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares

May 12, 2025, 6:30 PM EDT - 23 days ago

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

May 9, 2025, 11:44 AM EDT - 26 days ago

ANI Pharmaceuticals, Inc. (ANIP) Q1 2025 Earnings Call Transcript

May 9, 2025, 6:50 AM EDT - 26 days ago

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance

May 6, 2025, 5:43 AM EDT - 4 weeks ago

ANI Pharmaceuticals: A Short-Term Buying Opportunity

May 5, 2025, 7:00 AM EDT - 4 weeks ago

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

Apr 9, 2025, 6:50 AM EDT - 2 months ago

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

Mar 31, 2025, 4:30 PM EDT - 2 months ago

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

Mar 19, 2025, 6:50 AM EDT - 2 months ago

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

Mar 18, 2025, 6:50 AM EDT - 2 months ago

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

Mar 14, 2025, 6:50 AM EDT - 2 months ago

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

Mar 3, 2025, 4:30 PM EST - 3 months ago

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

Feb 28, 2025, 5:45 PM EST - 3 months ago

ANI Pharmaceuticals, Inc. (ANIP) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 10:37 AM EST - 3 months ago

ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual Forecast

Feb 28, 2025, 6:50 AM EST - 3 months ago

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

Feb 19, 2025, 4:30 PM EST - 3 months ago

ANI Pharmaceuticals to Present at Raymond James' Institutional Investors and Leerink Partners Global Healthcare Conferences in March

Feb 18, 2025, 4:05 PM EST - 3 months ago

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

Feb 11, 2025, 9:08 AM EST - 4 months ago

ANI Pharmaceuticals: More Than Just A Generics Company

Jan 28, 2025, 4:30 PM EST - 4 months ago

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

Jan 13, 2025, 11:12 AM EST - 5 months ago

Alcami Announces CEO Transition

Jan 13, 2025, 6:50 AM EST - 5 months ago

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

Jan 2, 2025, 6:50 AM EST - 5 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

Dec 30, 2024, 4:05 PM EST - 5 months ago

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 26, 2024, 4:30 PM EST - 6 months ago

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

Nov 8, 2024, 11:05 PM EST - 7 months ago

ANI Pharmaceuticals, Inc. (ANIP) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 6:50 AM EST - 7 months ago

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

Nov 4, 2024, 4:30 PM EST - 7 months ago

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

Oct 30, 2024, 5:00 PM EDT - 7 months ago

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

Oct 25, 2024, 6:50 AM EDT - 7 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

Oct 24, 2024, 6:50 AM EDT - 7 months ago

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

Oct 11, 2024, 1:40 PM EDT - 8 months ago

ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential

Oct 11, 2024, 4:01 AM EDT - 8 months ago

ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market

Sep 26, 2024, 6:50 AM EDT - 8 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

Sep 16, 2024, 8:53 AM EDT - 9 months ago

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

Sep 16, 2024, 6:50 AM EDT - 9 months ago

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

Sep 13, 2024, 6:50 AM EDT - 9 months ago

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

Sep 11, 2024, 6:50 AM EDT - 9 months ago

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

Sep 10, 2024, 2:09 PM EDT - 9 months ago

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

Sep 10, 2024, 9:00 AM EDT - 9 months ago

Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement

Aug 19, 2024, 6:20 PM EDT - 10 months ago

ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM

Aug 13, 2024, 4:05 PM EDT - 10 months ago

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers' Option to Purchase Additional Notes

Aug 9, 2024, 12:40 PM EDT - 10 months ago

ANI Pharmaceuticals, Inc. (ANIP) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 9:44 PM EDT - 10 months ago

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

Aug 7, 2024, 7:00 AM EDT - 10 months ago

ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering

Aug 6, 2024, 6:50 AM EDT - 10 months ago

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

Aug 2, 2024, 1:06 AM EDT - 10 months ago

ANI Pharmaceuticals: Tezruly Just Approved, 2 More NDAs Under Review And Alimera Science Acquisition Could Triple Revenue By 2028

Jul 15, 2024, 7:00 AM EDT - 11 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

Jul 2, 2024, 7:00 AM EDT - 1 year ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP